While on average women have more body fat than men, researchers say women’s reactions to a certain protein protect them from type 2 diabetes compared to their gender counterparts.

It is no secret that weight loss can greatly assist in the treatment of type 2 diabetes. However, a recent study shows that a specific drug, liraglutide, used at a certain dosage can yield weight loss for patients.

The U.S. Food and Drug Administration (FDA) recently approved Saxenda, an injectable drug developed by Novo Nordisk for obesity and weight management.

Scientists from Cornell University saw promising results in an animal study that could one day lead to the creation of a probiotic pill that can help control blood glucose.

A UCLA study shows only a small percentage of those diagnosed with prediabetes are given the first line type 2 medication. And considering its benefits for the type 2 patient population, the healthcare community and federal government may need to reconsider prescribing practices for this drug in the prediabetes patient population.

The U.S. Food and Drug Administration (FDA) recently announced that sodium-glucose cotransporter-2 (SGLT2) inhibitors can lead to increased levels of acid in the blood.